Protecting specific brain neurons from damage could be one way to treat or prevent Parkinson’s. Credit: National Institutes of Health
Scientists report that they have developed a novel compound that appears to protect mice against developing movement problems associated with Parkinson’s disease (PD).
The research, which could one day in the future translate into a therapy that could halt the progression of PD and thereby prevent the symptoms of the disease, appears in ACS’ Journal of Medicinal Chemistry.
Onyou Hwang, Ki Duk Park and colleagues explain that PD, which affects an estimated 4 million to 10 million people worldwide, is a progressive movement disorder with no known cure. It often starts with slight tremors and gets worse over time. Muscles go stiff. Walking becomes difficult. Speech is slurred. No one knows for certain what causes the disease, but research has shown that it’s linked with the loss of nerve cells in the brain that secrete dopamine, a chemical that is involved in movement and emotion. To find a potential new therapy for PD, the research team searched for a way to shield these brain cells.
They made 56 compounds and tested them to see which ones boosted the production of proteins that protect dopamine-releasing neurons from damage. Of those, one, which they call “12g,” proved to be the most active. Interestingly, it protected mice from developing PD-like symptoms in one laboratory test. “Taken together, 12g was found to effectively prevent the motor deficits that are associated with PD,” they say.
via The American Chemical Society
The Latest on: Parkinson’s disease
[google_news title=”” keyword=”Parkinson’s disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Parkinson’s disease
- Parkinson's disease patients join N.J. rehab facility choir to improve their conditionon December 6, 2022 at 3:47 pm
Some members of the Parkinsingers had no prior singing experience, but they're reveling in the chance to shine.
- ‘Sweet Caroline’: Neil Diamond delights fans with surprise performance four years after Parkinson’s diagnosison December 6, 2022 at 1:43 pm
Neil Diamond delighted Broadway fans with a surprise rendition of his hit song “Sweet Caroline” four years after his Parkinson’s diagnosis and an announcement that he was retiring from touring. The ...
- Former college football coach Mark Richt starts Parkinson’s treatment. What is levodopa?on December 6, 2022 at 12:12 pm
Considered the first-line drug for managing the effects of Parkinson’s on a person’s motor skills, levodopa is the “most potent medication” for the disease.
- BioVie shares latest updates on Alzheimer's and Parkinson's Disease clinical trialson December 6, 2022 at 11:15 am
BioVie President & CEO Cuong Do joins Natalie Stoberman from the Proactive studio to share the company's latest updates from ...
- Former college football coach ‘asking for your prayers’ as Parkinson’s treatment beginson December 6, 2022 at 9:45 am
Former college football head coach Mark Richt asked for prayers Tuesday morning as he begins a treatment for his Parkinson’s disease. Richt was a head coach for 18 seasons.
- Parkinson’s drug improves blood pressure, aortic stiffness in adolescents with Type 1 diabeteson December 6, 2022 at 9:08 am
Teens with Type 1 diabetes (T1D) who took bromocriptine, a medication used to treat Parkinson's disease and Type 2 diabetes, had lower blood pressure and less stiff arteries after one month of ...
- BioVie: Treating Alzheimer's, Parkinson's, And Potentially Reversing The Biological Clockon December 6, 2022 at 8:00 am
BioVie’s NE3107 has now shown improvement of cognition and function on different Alzheimer’s rating scales, supported by biomarkers and neuroimaging data. Read more here.
- Parkinson's medication improved blood pressure in teens with Type 1 diabeteson December 6, 2022 at 2:00 am
Teens with Type 1 diabetes (T1D) who took bromocriptine, a medication used to treat Parkinson's disease and Type 2 diabetes, had lower blood pressure and less stiff arteries after one month of ...
- BioVie announces positive results from two Phase 2 trials assessing NE3107’s potential in Parkinson’s Disease and Alzheimer’s Diseaseon December 6, 2022 at 1:55 am
BioVie Inc (NASDAQ:BIVI) has announced positive results from two Phase 2 trials assessing NE3107’s potential in Parkinson’s Disease (PD) ...
- Can Imbalances in the Gut Microbiome Cause Parkinson's Disease?on December 4, 2022 at 11:45 am
Now scientists have found evidence that certain bacteria in the gut microbiome are related to the development of Parkinson's disease. In this work, the researchers assessed stool samples from 490 ...
via Bing News
